Abstract: A thermal oxidizer (50) employing an oxidation mixer (51), an oxidation chamber (52), a retention chamber (53) and a heat dissipater (54) forming a fluid flow path for thermal oxidation of a waste gas. In operation, the oxidation mixer (51) facilitates a combustible mixture of the waste gas and an oxidant into an combustible waste gas stream. A heating element (55) of the oxidation chamber (52) facilitates a primary combustion reaction of the combustible waste gas stream into an oxygenated waste gas stream. The retention chamber (53) facilitates a secondary combustion reaction of the oxygenated waste gas stream into oxidized gases. The heat dissipater (54) atmospherically vents of the oxidized gases. An oxidization controller (61) may be employed to regulate the operation of the thermal oxidizer (50), and a data logger (63) and a data reporter (65) may be employed for respectively logging and remotely reporting a regulation of the thermal oxidizer (50) by the oxidation controller (61).

Abstract: Embodiments are described for a high-frequency waveguide that improves the performance of large-scale surround sound and immersive audio environments. A horn waveguide is configured to be asymmetric about one of a vertical axis and horizontal axis of the waveguide to form an asymmetric horn waveguide. A spherical enclosure surrounds the asymmetric horn waveguide to form a horn speaker, and a three-axis mounting system is configured to fix the horn speaker to one of a wall or ceiling surface of the venue, wherein the mounting system facilitates rotating the horn speaker to a location that provides maximum coverage of the venue within the passband of the asymmetric horn waveguide.

Abstract: A heat exchanger comprises a first tube having a first fin of a first predetermined height extending outward therefrom. A second tube is vertically spaced above the first tube. The second tube has a second fin of a second predetermined height extending outward therefrom. A fan is positioned to force ambient air across the second tube and then across the first tube to heat a fluid flowing therethrough. A method of heating a fluid comprises sequentially flowing the fluid upward through a plurality of vertically spaced rows of substantially horizontal tubes, and forcing air downward over the plurality of tubes to heat the fluid.

Abstract: An apparatus for vaporizing a cryogenic fluid comprises a heat transfer fluid closed circulation loop at least partially defined by an ambient air heat exchanger, a heater, and a vaporizer. The heat exchanger is configured to direct air downward across a plurality of heat exchanger tubes. A cryogenic fluid flows through the vaporizer. The plurality of tubes comprise a first tube having a first fin of a height, h1, and a second tube spaced adjacent the first tube, where the second tube has a second fin of a height, h2, wherein h2 is different from h1.

Abstract: A power feed arrangement for aggregate segments of a communications system is disclosed. In embodiments of the invention, cables are used to communicatively connect a number of landmasses, where the cables also serve to carry electrical power to devices connected along lengths of the cables. A first cable is connected to first and second landmasses, while a second cable is connected to second and third landmasses. On the second landmass, the electrical power conductors of the first and second cables are electrically connected to one another, and pieces of power feed equipment located on said first and third landmasses are used to supply electrical power to devices located along lengths of the first and second cables. Alternative embodiments are also disclosed.

Abstract: The invention provides novel non-?-lactam inhibitors of ?-lactamases. In particular, the invention provides boronic acid-based compounds set forth in the specification. These compounds may be used with ?-lactam antibiotics to bacterial infection, particularly, ?-lactam-antibiotic-resistant bacterial infections. These compounds are also antibacterial agents by themselves. The invention further provides methods of using such compounds. Finally, the invention provides a pharmaceutical composition comprising these compounds.

Abstract: A power feed arrangement for aggregate segments of a communications system is disclosed. In embodiments of the invention, cables are used to communicatively connect a number of landmasses, where the cables also serve to carry electrical power to devices connected along lengths of the cables. A first cable is connected to first and second landmasses, while a second cable is connected to second and third landmasses. On the second landmass, the electrical power conductors of the first and second cables are electrically connected to one another, and pieces of power feed equipment located on said first and third landmasses are used to supply electrical power to devices located along lengths of the first and second cables. Alternative embodiments are also disclosed.

Abstract: A first publically routable IP address and a second publically routable IP address (bypass IP address) is firstly received from an Internet Service Provider (ISP) that forms part of a public network. An instruction to assign the second publically routable IP address to the host computer is then received. The first publically routable IP address is assigned to a Network Address Translation (NAT) service on the gateway and the second publically routable IP address is allocated to the host computer. Finally, the second publically routable IP address is allocated to the host computer. This allows the host computer to be configured to enable it to receive unsolicited packets from the public network through the gateway. A gateway and computer program product are also provided.

Abstract: The invention provides novel non-?-lactam inhibitors of ?-lactamases. In particular, the invention provides boronic acid-based compounds set forth in the specification. These compounds may be used with ?-lactam antibiotics to bacterial infection, particularly, ?-lactam-antibiotic-resistant bacterial infections. These compounds are also antibacterial agents by themselves. The invention further provides methods of using such compounds. Finally, the invention provides a pharmaceutical composition comprising these compounds.

Abstract: The present invention relates to polypeptides that bind to RANK and comprise amino acid sequences of RANKL external surface loops. The invention also relates to fragments, analogs, and derivatives of such polypeptides.

Abstract: The present invention provides non-naturally occurring proteins that bind to RANK and polynucleotides encoding the same. The proteins of the invention can be used for enhancing bone formation by either inhibiting bone resorption or inducing osteogenesis.

Abstract: Method of screening osteogenic compounds utilizing RANK and/or RANK pathway, compositions comprising compounds selected thereby and method for enhancing bone mass comprising administering to a subject an effective amount of said compositions.

Abstract: The present invention provides crystals of RANKL ectodomain complexes, detailed three dimensional structural information illustrating the interaction between RANKL and RANK and methods of utilizing the X-ray crystallographic data from such crystals and other structural data disclosed to design, identify and screen for compounds that modulate activity. The present invention also relates to machine readable media embedded with the three-dimensional atomic structure coordinates of RANKL crystalline complexes and subsets thereof, together with other structural data disclosed herein.

Abstract: A method of enhancing bone formation comprising administering an effective amount of 1) an oligomeric complex of one or more of RANKL, a RANKL fusion protein or an analog, derivative or mimic thereof, 2) an osteogenic compound capable of enhancing activity of one or more intracellular proteins in osteoblasts or osteoblast precursors, wherein said activity is indicative of bone formation, or 3) an osteogenic compound capable of inactivating one or more phosphatases in osteoblasts or osteoblast precursors, wherein said inactivation is indicative of bone formation. The method also may be used to treat a disease or condition manifested at least in part by the loss of bone mass by administering to a patient a pharmaceutical composition comprising an oligomeric complex or osteogenic compound disclosed herein.

Abstract: A method and apparatus for monitoring electrodes for the electrodeposition of paint onto metallic workpieces includes detecting current from the electrodes and displaying a plot of current versus time. A method and apparatus for controlling electrodeposition of paint onto metallic workpieces includes monitoring current from electrodes over time and adjusting a rate of current increase over time. The monitor and/or control may be performed for each electrode individually or for the electrodes as a group. The monitor and/or control allows bad and/or poorly positioned electrodes to be located. The monitor and/or control may be used to stop the electrodeposition coating after a sufficiently thick coating has been obtained.